• Home
  • About
    • Mission & Overview
    • Our Team
    • Strategic Advisory Council
    • Veterans Advisory Council
    • Board of Directors
  • Brain Health
    • About Post-Traumatic Stress
    • About Traumatic Brain Injury
    • Patient & Veteran Perspectives
  • Programs
    • Our Programs
    • Roadmap
    • Advocacy
    • Publications & Resources
    • Traumatic Brain Injury
    • BRAIN Commons
    • Funding Opportunities
    • Legacy Programs
      • Multiple Sclerosis
      • – Orion MS 1.0
      • Biomarkers
      • – Resources
  • The Alliance
    • Cooperative Bionetwork
    • Our Sponsors
    • Our Partners
  • News & Events
    • News
    • Events
    • Webinars
    • Press
    • Newsletter
    • Brain Health Nexus
    • 22 Jumps
    • State of the Science Summit
    • Cohen Veterans Care Summit
  • Careers
  • Join The Fight
  • Donate
  • Contact
Cohen Veterans Bioscience
    • Home
    • About
      • Mission & Overview
      • Our Team
      • Strategic Advisory Council
      • Veterans Advisory Council
      • Board of Directors
    • Brain Health
      • About Post-Traumatic Stress
      • About Traumatic Brain Injury
      • Patient & Veteran Perspectives
    • Programs
      • Our Programs
      • Roadmap
      • Advocacy
      • Publications & Resources
      • Traumatic Brain Injury
      • BRAIN Commons
      • Funding Opportunities
      • Legacy Programs
        • Multiple Sclerosis
        • – Orion MS 1.0
        • Biomarkers
        • – Resources
    • The Alliance
      • Cooperative Bionetwork
      • Our Sponsors
      • Our Partners
    • News & Events
      • News
      • Events
      • Webinars
      • Press
      • Newsletter
      • Brain Health Nexus
      • 22 Jumps
      • State of the Science Summit
      • Cohen Veterans Care Summit
    • Careers
    • Join The Fight
    • Donate
    • Contact

    News

    Cohen Veterans Bioscience > News
    • Alzheimers & Dementia journal logo

      Orion CEO Co-Authors 2014 Report on the Milestones for the US National Plan to Address Alzheimer’s Disease

      October 20, 2014

      Orion CEO & Founder Magali Haas was a co-author of the Alzheimer’s Association 2014 Report on the Milestones for...

      Cohen Veterans Bioscience
    • Orion Bionetworks in the news

      Orion in the News: “Buckets of money for the brain” by Science-Business eXchange

      September 29, 2014

      Orion Bionetworks founder Magali Haas was quoted in this article about financing for the study of neurological disorders.

      Cohen Veterans Bioscience
    • Navigating the new road in psychiatry

      August 19, 2014

      Navigating the new road in psychiatry By C. Simone Fishburn, Executive Editor, and Lev Osherovich, Senior Writer – Science-Business...

      Cohen Veterans Bioscience
    • Dr. Iya Khalil - Building Bridges to Improve Lives

      PharmaVOICE: Dr. Iya Khalil – Building Bridges to Improve Lives

      August 14, 2014

      Dr. Iya Khalil, Co-founder and Executive VP of GNS Healthcare (an Orion Bionetworks Partner), was featured in PharmaVOICE July/August...

      Cohen Veterans Bioscience
    • Decoding Brain Disease - article snippet

      Decoding Brain Disease

      April 22, 2014

      Orion’s pilot project to understand the complex human experience of MS with powerful computers is at the early stage…

      Cohen Veterans Bioscience
    • Opinion: Predicting Perfect Storms

      Predicting Perfect Storms

      October 30, 2013

      In MS, genetics, environment, and hundreds of other factors come together to elicit the immune system attack on neurons…

      Cohen Veterans Bioscience
    • Thomson Reuters Collaborates with Orion Bionetworks to Advance the Understanding of Multiple Sclerosis

      Thomson Reuters Collaborates with Orion Bionetworks

      October 22, 2013

      Thomson Reuters Collaborates with Orion Bionetworks to Advance the Understanding of Multiple Sclerosis Alliance to develop predictive disease models...

      Cohen Veterans Bioscience
    • Rancho BioSciences to Curate Extensive Multiple Sclerosis Database

      Rancho BioSciences to Curate Extensive Multiple Sclerosis Database

      July 2, 2013

      Rancho BioSciences is helping the Accelerated Cure Project by curating and preparing diverse data sets coming in from researchers…

      Cohen Veterans Bioscience
    • Consortium to Develop Disease Model for Multiple Sclerosis

      Consortium to Develop Disease Model for Multiple Sclerosis

      March 4, 2013

      A coalition of research institutes, analytics companies, and a patient network are building computational tools and models to better…

      Cohen Veterans Bioscience
    • Previous
    • 1
    • ...
    • 14
    • 15
    • 16
    • 17
    • 18

    Webinar Series

    Transforming Concussion Care

    Parachuting with Purpose: A View into the Personal Experiences of Traumatic Brain Injury Among Veterans and a New Path Toward Precision Solutions

    Webinar: Advancing our understanding of neuroinflammation: Driving a systems biology approach to re-classify brain disease

    Webinar Archives

    Transforming Concussion Care

    Watch this webinar for insights and updates on brain injury treatment approaches from experts at Coh[...]

    Parachuting with Purpose: A View into the Personal Experiences of Traumatic Brain Injury Among Veterans and a New Path Toward Precision Solutions

    Cohen Veterans Bioscience hosts a conversation with Veteran BASE Jumpers of 22 Jumps on Mental Healt[...]

    Webinar: Advancing our understanding of neuroinflammation: Driving a systems biology approach to re-classify brain disease

    [...]

    Webinar: Biomarkers on the Brain: Understanding the Utility of Biomarkers for Brain Health and Disease

    [...]

    News

    Music and motorcycles: Two passion projects help raise money for Traumatic Brain Injury research

    May 5th, 2022

    How to Maintain Your Mental Health

    April 27th, 2022

    The Global Preclinical Data Forum, Cohen Veterans Bioscience and European College of Neuropsychopharmacology Announce 2022 Best Negative Data Prize in Preclinical Neuroscience

    March 15th, 2022

    Women in Science: A Conversation with the Women Scientists of Cohen Veterans Bioscience

    March 2nd, 2022

    Traumatic Brain Injury: A Framework to Advance Biomarker Development for Diagnosis, Outcome Prediction, and Treatment

    February 10th, 2022

    Events

    22 Jumps: Memorial Day Weekend 2022, Twin Falls, Idaho

    SOBP Training Workshop: “Enhancing the Utility of Preclinical Animal Models for Advancing CNS Therapeutics”

    22 Jumps: January 30th, 2022 at Camelback Mountain, Arizona

    Brain Health Nexus - October 18-19, 2022

    Video: A Conversation with Veteran BASE Jumpers of 22 Jumps

    Help Us Make Brain Disorders Predictable, Treatable & Curable
    WHO WE ARE
    Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
    Learn More Donate
    LEARN MORE ABOUT OUR MISSION
    Get News & Updates

    Get Email Updates

    Guidestar Platinum Transparency 2021

    Member of the American Brain Coalition

    ©2022 Cohen Veterans Bioscience
    Powered by Tone Creative

    • Privacy Policy
    • Terms of Use
    • FCOI Policy
    • Indirect Cost Policy
    • Careers
    • Contact Us
    • Donate
    Manage Cookie Consent
    We use cookies to optimize our website.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View Preferences
    {title} {title} {title}
    Manage Cookie Consent
    We use cookies to optimize our website.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View Preferences
    {title} {title} {title}